Study on efficacy and safety of low-dose regimens of rituximab for refractory myasthenia gravis

doi:10.3969/j.issn.1672-3384.2025.03.012

Yangai WANG, Boyang ZHI, Wenjia ZHU, Xiangrong BAI, Yanqi CHU

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (3) : 74-77.

PDF(419 KB)

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (3) : 74-77. DOI: 10.3969/j.issn.1672-3384.2025.03.012

Original Article

Study on efficacy and safety of low-dose regimens of rituximab for refractory myasthenia gravis

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(3): 74-77 https://doi.org/10.3969/j.issn.1672-3384.2025.03.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(419 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2024-12-06	2025-03-10
Issue Date
2025-04-01

Please choose a citation manager

Content to export